Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis. Rustgi SD, Oh A, Yang JY, Kang D, et al. BMC Cancer 2021;21:597.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rustgi SD, Oh A, Yang JY, Kang D, et al. Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis. BMC Cancer 2021;21:597.
PMID: 34030646